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Abstract

Introduction

The risk of crystallization in solutions, with a
composition corresponding to that of urine in various
parts of the nephron, was assessed by studying urine
samples containing standardized increments of calcium
and oxalate concentrations.
The experiments were carried out in salt solutions with and without dialysed urine
and the appearance of crystals was detected and measured with a Coulter counter. With increased concentrations of calcium, crystals of calcium phosphate were predominantly formed in solutions with a composition corresponding to that in the proximal and distal tubuli,
whereas, calcium oxalate was the primary crystallization
product in solutions with a composition corresponding to
the collecting duct. These conclusions were based on
calculations of ion-activity products of calcium oxalate,
hydroxyapatite, and calcium hydrogen phosphate, at the
first appearance of crystals; studies on crystal morphology with scanning electron microscopy, and precipitation
of [ 14 C]-oxalate following addition of calcium. The ionactivity products of calcium oxalate at the first appearance of crystals following addition of oxalate to solutions with a composition corresponding to the collecting
duct were significantly lower in the presence of dialysed
urine. This might reflect a promoting effect of some
macromolecules on the nucleation of calcium oxalate.
Dialysed urine in these samples also had a pronounced
influence on the development of the crystals by markedly
reducing the mean crystal volume during the first hour
following the formation of 100 crystals with a diameter
between 3.5 and 5 µm. Such an effect was not observed
in those solutions in which calcium phosphate crystals
had formed.

The mechanisms behind the formation of calcium
renal stones are incompletely understood, particularly
concerning the initial crystallization events. With sensitive stone analyses, it has become apparent that a large
proportion of these stones are composed of mixtures of
calcium oxalate and calcium phosphate (Prien, 1955; Pak
et al., 1971; Chambers et al., 1972; Larsson et al.,
1984a, b; Ohkawa et al., 1992). A comparison of urine
composition in patients with different stones also showed
that the excretion of oxalate obviously was increased in
patients with pure calcium oxalate stones, this was usually not the case in patients with mixed stones. Stones
containing both calcium oxalate and calcium phosphate
appeared to be associated with other risk factors than
stones with only calcium oxalate (Peacock et al., 1979;
Ohman et al., 1992).
It is reasonable to assume that the formation of
renal stones starts as a crystallization at the nephron
level, probably due to an interaction of the driving force
of the supersaturated urine and the cells lining the tubuli
or the collecting ducts.

When we estimated the supersaturation levels of
calcium salts in different parts of the nephron based
upon the information in the literature (Rector, 1973;
Koushanpour, 1976; Robertson, 1976; Tiselius et al.,
1978; Tiselius, 1982; Simpson, 1983; Kasidas and Rose,
1986), the data indicated that the risk of calcium phosphate crystallization might exceed that of calcium oxalate. This appeared to be the case particularly for a urine
composition corresponding to that in proximal tubuli,
loop of Henle, and distal tubuli. High supersaturation
levels and a risk of precipitation of both calcium phosphate and calcium carbonate in the tubular system, particularly the loop of Henle, also has been reported recently (Coe and Parks, 1990; Deganello et al., 1990).

Key Words: Crystallization, calcium oxalate, calcium
phosphate, renal tubuli, collecting duct, promotion,
inhibition, urine, macromolecules.
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The present study was undertaken as an attempt to
increase our understanding of the formation of crystals
in association with increased concentrations of calcium
and oxalate in a urine with a composition otherwise
similar to that in the parts of the nephron.
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Table 1. Composition of salt solutions corresponding
the nephron.
Proximal tubuli
(PT)

to that in urine from different parts of

Distal tubuli
prox part (DTp)

Distal tubuli
dist part (DTd)

Collecting ducts
(CD)

Calcium

mmol/1

2.78

1.32

1.04

Magnesium

mmol/1

0.09

0.12

0.41

Phosphate

mmol/1

1.00

1.25

4.17

Oxalate

mmol/1

0.010

0.013

0.04

0.32

Citrate

mmol/1

0.08

0.10

0.35

3.21

Sodium

mmol/1

Potassium

mmol/1

3.2

0.95

22.5

63.7

Sulfate

mmol/1

3.3

4.2

13.8

20.8

6.75

6.45

pH

139

82

Methods

96

6.45

4.50
3.85
32.3

106

5.75

and sulfate in PT (Koushanpour, 1976; Lingeman et al.,
1989) were assumed to be 140 and 80-90 mmol per 24
hours, respectively.
Eighty per cent of filtered sodium
is reabsorbed in PT. Of the total filtered sodium, 9.4%
has been reported to remain in PT, 3.3% in DT, and
0.7% in CD (Koushanpour, 1976). The reabsorption of
potassium in PT was considered to be 84%, with 3.8%
of filtered potassium remaining in DTp and 27% in DTd,
attributable to an inflow of potassium.
At the end of
CD, 91.4% of filtered potassium was assumed to be reabsorbed (Koushanpour, 1976).
The pH in the samples was chosen according to
results reported by Rector (1983) with 6.7-6.8 in PT;
6.4-6.5 in DT; and 5.6-6.0 in CD.
These solutions were used in the crystallization
experiments either with or without the addition of dialysed urine. In order to avoid any risk of precipitation
of ammonium salts, we added no ammonium ions to the
solutions, despite the normal presence of this ion both in
the distal tubuli and the collecting ducts. Because of
technical difficulties in preparing a CD solution according to these calculations, we used a composition of the
CD sample described for urine by Burns and Finlayson
(1980).
The amount of dialysed urine added to the samples was roughly calculated from the degree of dilution
at different nephron levels in comparison with the final
urine. Dialysed urine was added to the PT and the DTp
samples to give a 10% concentration of urine. The DTd
samples were analyzed with a 20% urine concentration,
while the CD sample was prepared by dissolving the
necessary salts in the dialysed urine.

Crystallization systems
Several salt solutions were prepared in accordance
with the assumed ion composition of urine in the proximal tubuli (PT), the proximal part of the distal tubuli
(DTp), the distal part of the distal tubuli (DTd), and the
collecting ducts (CD). The compositions of these solutions, which is summarized in Table 1, were based on
data in the literature concerning ion-concentrations
in
the nephron, information on the renal handling of the
constituents, as well as their plasma concentrations and
excretion in urine. For these calculations, we assumed
that the concentrations of the various urine variables in
the glomerular filtrate were as follows: calcium: 1.5
mmol/1; oxalate: 2 µmol/1; magnesium: 0.54 mmol/1;
phosphate: 1.35 mmol/1; sodium: 135 mmol/1; potassium: 3.8 mmol/1; citrate: 0.07 mmol/1; sulfate: 1.4
mmol/1; and pH: 7.4 (Koushanpour, 1976; Robertson,
1976; Cohen and Barac-Nieto, 1983; Kasidas and Rose,
1986; Simpson, 1983). An average 24-hour volume of
the glomerular filtrate of 180 liters was expected to be
reduced to 36 liters at the end of PT; 28.8 liters at the
end of Henle' s loop; 8. 6 liters at the end of DT; and
1.44 liters at the end of CD (Koushanpour, 1976). The
concentrations of calcium were based on a reabsorption
of63% in PT, 23% in DTp, 11% in DTd, and 1% in CD
(Lassiter et al., 1963; Robertson, 1976). The reabsorption of magnesium, which mainly occurs in the proximal
part of the nephron (Walser, 1983) was roughly assumed
to be 93% in PT and 3.5% in DT.
The concentration of oxalate was considered to be
affected only by the volume reduction of urine and no attention was paid to any secretion or passive reabsorption
that might occur. The reabsorption of citrate varies considerably with the acid base balance, but has been
reported to be around 75 % under normal circumstances
(Robertson, 1976). This value was used as an estimate
of the reabsorption of citrate in PT. The tubular reabsorptive capacities for phosphate (Koushanpour, 1976)

Preparation of dialysed urine
A pooled sample of urine from normal subjects
was used as a source of macromolecules. This urine had
been prepared according to our routine for direct determination of the risk of crystallization (Tiselius, 1985).
This urine had been collected between IO PM and 6 AM
in bottles containing 15 ml of 3 mmol/1 sodium azide.
Each sample was checked for the absence of bacteria,
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Crystallization of calcium salts in the nephron
Determination of crystallization following addition of
calcium chloride
One hundred milliliter samples of the salt solutions, with or without dialysed urine, were passed
through 0.22 µm Millipore filters. A solution of calcium chloride was added in 100 µl fractions to the PT,
DTd, and CD samples, and in 200 µl fractions to the
DTp samples. Calcium chloride was added every minute
and the number of crystals recorded 40 seconds later
with a Coulter counter (Model ZB) equipped with channelyser (Coulter Electronics Ltd, Luton, U.K.) using a
100 µm capillary tube. Only those crystals were considered that appeared in the size interval of 3.5 to 5.0 µm,
and the addition of calcium was stopped when 100 crystals had been recorded in a volume of 50 µl. The pH
was maintained by repeated addition of small aliquots of
0.05 mol/1 sodium hydroxide.
Due to differences in the crystallizati0::-1pwyensity, two concentrations of calcium chloride were used
in the experiments. A 1.0 mol/1 calcium chloride solution was used for PT, DTp, and DTd samples, while, a
0. 7 mol/1 solution was used in the experiments with CD
samples.
A typical crystallization experiment is shown in
Figure 1. The concentrations of the constituents of the
samples at the first appearance of crystals, as well as at
the formation of 100 crystals were recorded. Corrections were made for changes in the volume as a result of
crystal counting. These data were subsequently used for
calculation of the ion-activity products of calcium oxalate (APcaox); hydroxyapatite (APHAP); and calcium hydrogen phosphate, brushite (APBru); by means of a computerized iterative approximation with the EQUIL2 program (Werness et al., 1985). The risk of crystallization
was also expressed as the increment in calcium concentration necessary for formation of crystals in the size
range 3.5 to 5 µm.
Determination of crystallization following addition of
sodium oxalate
One hundred milliliter samples of salt solutions,
with or without dialysed urine, were passed through 0.22
µm Millipore filters. A solution of 0.04 mol/1 sodium
oxalate was added in 100 µl fractions to all samples.
Sodium oxalate was added every minute and the number
of crystals recorded 40 seconds later as described above
for the calcium experiment (Tiselius, 1985). The concentrations of the constituents were recorded in a similar
way, both at the first appearance of crystals and at the
formation of 100 crystals in the size range 3.5 to 5 µm.
The pH was checked before and after crystallization and
remained constant.
Determination of mean crystal volumes
As soon as 100 crystals had been recorded following addition of the calcium, the samples were kept under
magnetic stirring during the following 60 minutes. Aliquots were drawn from all samples after 15 and 60 minutes for analysis of crystal size distribution in a Coulter
Multisizer with a 100 µm capillary tube. The number
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Figure 1. A typical result of the crystal formation in a
sample following standardized addition of calcium. The
recording of crystals was made in the size range 3.5 to
5 µm in a Coulter counter 40 seconds after each addition
of 100 µl of a 1 mol/1 calcium chloride solution.

protein, and glucose, after which pH was adjusted to
5. 8. The urine was subsequently centrifuged at 2800
rpm for 30 minutes. The supernatants were decanted
and saved, and the sediments were combined in one
tube. Following repeated centrifugation of the sediment
fraction, this supernatant was combined with the previously collected supernatants. The crystals in the sediment were dissolved by addition of 1 mmol/1 hydrochloric acid. After centrifugation and neutralization, this
supernatant was combined with the other urine.
The undissolved material in the tube was discarded. The pH of the urine was now readjusted to 5.8.
One hundred milliliter aliquots of the pooled urine were
then transferred to Spectrapore No. 3 dialysis tubings
with an exclusion limit of 3500 Da (Spectrum Medical
Industries, Inc., Houston, Texas). Each tubing was
placed in 1000 ml of deionized water with magnetic stirring at room temperature. The water was exchanged
eight times, once every hour. During the following 15
hours, still under continuous stirring, the samples were
kept in deionized water at +4 °C, after which the deionized water was replaced by Milli-Q filtered water (Millipore, S.A, Molsheim, France), exchanged six times,
once every hour. The samples were subsequently filled
up to the original volume with water and stored at -20°C
until used in the experiments.
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and volume of the crystals were determined in the size
interval between 3.5 and 45 µm. The mean crystal volume (MCV) was obtained by dividing the total volume
(µm 3) by the total number of crystals. We also calculated MCV-quotients: MCV 60 / MCV 15 , to express the
changes in crystal volume that occurred during the
observation period.

is evident that the APcaox values in both PT and DTp
samples were below that level. These solutions were
thus undersaturated with CaOx at the time of crystal
formation, and the only type of crystal observed in PT
and DTp samples was calcium phosphate. Although the
APcaox in DTd samples was above the solubility product, this supersaturation is certainly too low to be
associated with a nucleation of CaOx. In contrast, the
CD samples were highly supersaturated with CaOx.
The APHAP values corresponding to the first appearance of crystals as well as when 100 crystals with
diameters between 3.5 and 5 µm were recorded, are
given in Table 3. The lowest supersaturation levels associated with the formation of calcium phosphate crystals was observed in the DTd samples. The formation
product of HAP is unknown, but the APHAP values in all
samples were considerably above the solubility product
for HAP, which is reported to be approximately 2 .4 x
10-59 M 9 (Koutsoukos and Nancollas, 1981).
The pH levels in the nephron are consistent with
precipitation of calcium hydrogen phosphate and in as
much as some crystals observed in the PT, DTp, DTd,
and CD samples, 60 minutes after the end point in the
calcium experiments, had a brushite-like appearance, we
also calculated the AP 8 ru in the different samples (Table
4). Although the supersaturation with this salt was below the reported formation product [2 x 10-7 (mol/1)2],
the values exceeded the solubility product of 0.9 to 1.3
x 10-7 (Koutsoukos and Nancollas, 1981; Nancollas,
1982) in PT, DTp, and DTd samples. The AP 8 ru at the
first appearance of crystals were significantly lower in
DTp-samples with dialysed urine (p < 0.01) and higher
in CD-samples with dialysed urine (p < 0.01).
The ion-activity products of CaOx, HAP and
brushite at the crystallization that followed increased
concentrations of oxalate are shown in Tables 5, 6 and
7. In all solutions, except in the CD samples, the
APcaox required for oxalate induced crystallization was
significantly higher (p < 0.01) than that associated with
crystallization
following addition of calcium.
The
APHAP and AP 8 ru levels recorded at crystallization following addition of oxalate were significantly lower (p <
O.Ol) than those observed following addition of calcium.
The risk of crystallization expressed as the relative increment in the concentrations of calcium and oxalate, required for the formation of crystals in the individual solutions, is shown in Table 8. It is evident that
a great risk of crystallization following addition of calcium occurred in PT, DTd, and CD samples, while CD
samples showed the greatest risk following the addition
of oxalate. In the PT and DT samples, a much higher
relative increment in the concentration of oxalate than of
calcium was necessary to induce crystal nucleation.
The concentration of [ 14C]-oxalate remaining in
solution at several concentrations of calcium is shown in
Figure 2. There was evidently a marked precipitation of
oxalate only in the CD samples, with a consumption of
isotope in PT, DTp, and DTd samples, with or without
urine, of less than 5 % . There was, however, a marked

Microscopic examination of the crystals
Aliquots for examination of the crystal material
after addition of calcium chloride were obtained from
samples treated in the same standardized way as described above. Samples were drawn just before the expected appearance of 3.5 to 5 µm crystals in the solution. These samples were isolated for scanning electron
microscopy (SEM) by passing them through polycarbonate membrane filters with a pore size of 0. 2 µm
(Poretics corp, Livermore, CA, USA). The filters were
rinsed with air, dried at room temperature, and mounted
with double stick tape on metallic stubs. The crystals
were then covered by a 10 nm layer of metallic platinum
in a twin electron beam gun sputter coating unit
(Edwards Model 3AM, Crawley, Sussex, U.K.).
The
crystals were examined in a JEOL JSM-840 SEM
(Tokyo, Japan).

Isotope-studies

of crystallization

In this experiment calcium chloride was added to
PT, DTp, DTd, and CD samples containing 10 µCi of
14
[ C]-oxalate per ml. The [ 14C]-oxalic acid solution had
a specific radioactivity of 109 µCilµmol (Amersham,
Buckinghamshire, U .K.). After each addition of calcium
chloride to 100 ml of the experimental solution, aliquots
of one milliliter were drawn for assessing the amount of
isotope remaining in solution. After passage of the sample through a 0.22 µm Millipore filter, 0.5 ml was immediately added to 10 ml of scintillation fluid (Maxifluor, J T Baker BY, Deventer, Netherlands).
The isotope concentration was measured in a liquid scintillation
spectrometer
(LKB Wallac 1217, Turku, Finland).
Quench correction was performed by means of an internal standard.

Calculations of ion-activities
For calculation of the ion-activity product of HAP
we used the structure Ca 5 (PO 4))(OH).
Statistics
Mann-Whitney
comparisons.

U test were

used for sample

Results
The ion-activity products of calcium oxalate
(APcaox) at the first appearance of crystals in salt
solutions, with and without dialysed urine, following
addition of calcium, are presented in Table 2. The
saturation with respect to CaOx was very low in all
solutions except in the CD samples. With a thermodynamic solubility product for CaOx of 0.23 to 0.25 x 10-8
M 2 (Pak et al., 1975; Tomazic and Nancollas, 1979), it
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Figure 2. Per cent of [14 C]-oxalate remaining in solution following addition of calcium to solutions without and
with dialysed urine.
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Table 2. Ion-activity products of calcium oxalate (APcaox) at different points of crystallization
which calcium was added.

in the experiments

in

Samples
10 8

X

M2

Before calcium addition
Mean (Standard

deviation,

PT

DTp

DTd

CD

0.103

0.102

0.154

1.95

Without dialysed urine

SD)

At first appearance of crystals
in the size range 3.5-5 J.Lm

0.11 (0.004)m

0.10 (O.Ol)m

0.63 (O.Ol)m

4.15 (0.06)

At 100 crystals
in the size range 3. 5-5 J.Lm

0.09 (0.005)m

0.09 (O.Ol)m

0.63 (0. lO)'n

4.25 (0.02)

=

n

10

n

=

10

=

n

=

n

10

11

Wirh. dialysed urine
At first appearance of crystals
in the size range 3.5-5 J.Lm

o. 11 co.oo6r

0.12 (0.08)m

0.63 (0.14)m

4.22 (0.06)

At 100 crystals
in the size range 3.5-5 J.Lm

0.09 (0.003)m

0.10 (0.0l)m

0.62 (0.15)m

4.18 (0.07)

=

n
Compared

10

n

=

10

=

n

=

n

10

9

to samples following addition of oxalate: mp < 0.01.

Table 3. Ion-activity products of hydroxyapatite
which calcium was added.

(APHAP) at different

points of crystallization

in the experiments

Samples
PT
Before calcium addition

3.40

X

DTp

10-4?

2.29

Mean (SD)
At first appearance

DTd

10-50

X

7.85

X

CD

10-50

3.66

X

10-44

0.61

X

10-49

Without dialysed urine
of crystals

in the size range 3. 5-5 J.Lm
At 100 crystals
in the size range 3.5-5 J.Lm

2.17 X 10-42
(1.36 X 10-42)m
6.56
( 1. 78
n

X
X

=

0.86
(0.43

10-42

X

J .37

10-42)m

(0. 70

10

X

n

X

X

=

10-42
10-42)m

(1.87 x 10-44)m

10-42
J0-42)'n

6.00 X 10-44
(4.06 10-44)m

10

2.08

n

X

=

10

(0. 22
2.11
(0.51

X

X

X

10-45
10-45)m

10-45
10-45)m

n = 11

With. dialysed urine
At first appearance

of crystals

in the size range 3. 5-5 J.Lm
At 100 crystals
in the size range 3.5-5 J.Lm

2.58 X 10-42
(1.06 X 10-42)m
7.93
(1.38
n

X

X

=

10-42
10-42)'n

0.29
(0.13

X

X

10-42

10-42rn,b

10-42

0.87 X
(0.26 X J0-42)m,b

n

10

Compared with samples without dialysed urine: bp < 0.01;
Compared with samples following addition of oxalate: mp < 0.01

52

=

10

3.06
(2.75
10. 8
(7.52
n

X
X

10-44
10-44)m

44
X 10X

=

10-44)m
10

1.97
(0.24

X
X

7.22
(0.47

X
X

n

10-45
10-45)m
10-45
10-4S)m

=9

in
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Table 4. Ion-activity products of calcium hydrogen phosphate (APBru) at different points of crystallization
experiments in which calcium was added.

in the

Samples
107

X

M2

Before calcium addition

PT

DTp

DTd

CD

0.87

0.46

0.76

4.21

Without dialysed urine

Mean (SD)
At first appearance of crystals
in the size range 3.5-5 µm

5.58 (0. !6)m

7.23 (0.3l)m

7.50 (l. l 7)m

17. 1 (I. lO)m

At 100 crystals
in the size range 3.5-5 µm

6.20 (0.18)m

7.76 (0.24)m

9.39 (0.82)m

21.6 (l.lO)m

n

=

10

n

=

10

n

=

10

n

=

11

With dialysed urine
At first appearance of crystals
in the size range 3.5-5 µm
At 100 crystals

in the size range 3.5-5 µm

5.53 (0.26)m

6.52 (0.21r,a

7.99 (l.56)m

20.7 (0.32)m,a

6.28 (o. 13r

7.28 (0.19)m,a

10.43 (l.06)m,a

26. I (0.40)m,a

=

n = 10

n = 10

n = 9

n

10

Compared with samples without dialysed urine: ap < 0.05; bp < 0.01
Compared with samples following addition of oxalate: mp < 0.01

Table 5. Ion-activity products of calcium oxalate (APcaox) at different points of crystallization
which oxalate was added.
108

X

Samples

M2

Before oxalate addition

in the experiments in

PT

DTp

DTd

CD

0.103

0.102

0.154

1.95

Mean (SD)

Without dialysed urine

At first appearance of crystals
in the size range 3.5-5 µm

4.94 (l .05)m

4.38 (0.90)m

4.05 (0.8l)m

5.30 (0.07)

At 100 crystals
in the size range 3.5-5 µm

6.49 (0.27)m

4.97 (0.78)m

4.51 (0.7l)m

5.70 (0.19)

n = 10

n = 10

n = 10

n

=

10

With dialysed urine
At first appearance of crystals
in the size range 3.5-5 µm
At 100 crystals
in the size range 3.5-5 µm

3.97(0.!7)m

4.85 (0.94)m

3.87 (0.85)m

5.01 (0.23t

5.20 (l.03)m,a

5. 65 (0. 86)m

4.38 (0.84)m

5.62 (0.41)

n = 10

n = 10

n = 10

Compared to samples without dialysed urine: 8p < 0.05;
Compared to samples following addition of calcium: mp < 0.01.

53

n

=

10
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Table 6. Ion-activity products of hydroxyapatite
which oxalate was added.

(APHAP) at different

points of crystallization

in the experiments

in

Samples
PT
Before oxalate addition

DTp

3.40 X 10-47

2.29

DTd

10-50

X

7.85

CD

1O-50

X

3.66 X 10-49

Without dialysed urine

Mean (SD)
At first appearance

of crystals

in the size range 3.5-5 µm

2.46
(0.18
2.21

At 100 crystals
in the size range 3.5-5 µm

(0.04
n

47
X 10X

1.33

10-47 )m

(0.16

10-47

X

X

1.23

47
X 10- )m

(0.13

= 10

X

X
X

10-50
10-50)m
10-50
10-50)m

4.16
(0.61
3.83
(0.50

n = 10

n

X
X
X
X

10-50
10-50)m
10-50
10-50)m

=

3.19

10-49

X

(0.08

10-49 )m

X

3.12

10-49

X

(0.03 1O-49 )m

= 10

n

10

With dialysed urine
At first appearance

of crystals

2.63

in the size range 3. 5-5 µm

(0.03

At 100 crystals
in the size range 3.5-5 µm

2.42
(0. 17

47
X 10-

1.25

X 10-47 )m
X

X

(0. 16

to samples following

addition of calcium:

Table 7. Ion-activity products of calcium
experiments in which oxalate was added.

X

10-50
10-50)m

1. 12 X 1o-50
(0.13 X 10-50)m

10-47
10-47 )m

n = 10
Compared

X

n

=

4.30
(0.66
3.93
(0.59
n

10

X
X
X
X

10-50
1O-50)m

(0.04

10-50
10-50)m

3.13
(0.07

=

10

3.23

n

10-49

X
X

X
X

10-49 )m
10-49
10-49 )m

=

10

mp < 0.01.

hydrogen

phosphate

(AP 8 ru) at different

points of crystallization

in the

Samples

Before oxalate addition

PT

DTp

DTd

CD

0.87

0.46

0.76

4.21

Without dialysed urine

Mean (SD)
At first appearance of crystals
in the size range 3.5-5 µm
At 100 crystals

0.82 (O.Ol)m

0.42 (O.Ol)m

0.66 (O.O2)m

4.07 (O.O2)m

0.80 (O.O03m

0.41 (O.Ol)m

0.65 (O.O2)ffi

4.05 (O.Ol)m

in the size range 3.5-5 µm
n

=

10

n

=

10

n

=

10

n

=

10

With dialysed urine
At first appearance of crystals
in the size range 3.5-5 µm

0.83 (O.OO2)m

0.41 (O.Ol)m

0.67 (O.O2)m

4.08 (O.Ol)m

At 100 crystals
in the size range 3.5-5 µm

0.82 (0 OOl)m

0.40 (O.Ol)m

0.66 (O.O2)m

4.06 (O.O2)m

n
Compared

to samples following

=

10

addition of calcium:

n
mp < 0.01.
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Table 8. Increments in the concentrations of calcium (A calcium) and oxalate (A oxalate) necessary for detection of
crystals in the size range 3.5 to 5 µm in samples without and with (dU) dialysed urine. The relative increment was
expressed as the quotient between the A calcium and the initial calcium concentration and between A oxalate and the
initial oxalate concentration, respectively.
Calcium addition
A calcium
mmol/1
PT
DTp
DTd
CD
PT+

dU

DTp + dU
DTd + dU
CD+ dU

Oxalate addition
A oxalate
mmol/1

Relative
increment

Relative
increment

30.3 (2.0)

10.9

0.49 (0.1)

49.0

50.5 (5.8)
9.8 (2.0)
7.5 (1.1)

38.2
9.4

0.60 (0.14)
1. 15 (0.26)

45.9
28.8

I. 7

0.57 (0.01)

1. 8

29.8 (3.1)
39.3 (3.6)
10. 7 (2. 7)

10.7
29.8

0.39 (0.02)

38.7

0.67 (0.14)
1.08 (0.27)
0.52 (0.04)

51.3
27.0

11.0(3.1)

10.3
2.4

difference in the crystallization of CaOx when the CD
samples, with and without dialysed urine, were compared, with a much slower precipitation of oxalate in the
presence of urine.
Scanning electron microscopy of the precipitate
close to the first appearance of crystals in the size-range
3.5 to 5 µm showed that calcium phosphate, was probably the only early material in PT, DTp and DTd samples, following addition of calcium (Figures 3 and 4).
In CD samples, with and without dialysed urine, CaOx
was the only early crystal phase. When DTd and CD
samples were further supersaturated by addition of calcium until 100 crystals in the size range 3.5 to 5 µm had
formed, brushite crystals were frequently observed after
60 minutes.
The MCV following addition of calcium (Table 9)
increased between 15 and 60 minutes with a factor of 1.6
to 5.5 in PT, DTp and DTd samples without dialysed
urine. The corresponding figures in samples containing
urine were 1.2 to 2.5. However, a most pronounced difference was recorded in the CD experiments, in which
the MCV markedly increased in the absence of dialysed
urine 36. l compared with 1.04.

1.6

Table 9. Mean (SD) of the mean crystal volumes
(MCV) and MCV-quotients at different ti mes after formation of 100 crystals with a diameter between 3.5 and
5 µm following increment of the calcium concentration
in solutions without and with dialysed urine.
MCV 15 min MCV 60 min
µm3
µm3
PT
DTp
DTd
CD
PT+ dU
DTp + dU
DTd + dU
CD+ dU

92.6 (22.4) 192.1 (56.6)
62. 6 ( 13. 6) 351.2 (306.1)
71.3 (38.5)
93.3 (30.9)
65.2 (10.5) 2161 (1405)
56.5 (11.2)
110 (20.3)
63.4 (11.6)
158 (56. 7)
91. 8 (4 7. 7) 93.3 (52.1)
72.8 (39)
76.3 (22.3)

MCV60/
MCV15
2.14 (0.72)
5.51 (4.82)
1.57 (0.85)
36.1 (24.9f
2.01 (0.54)
2.49 (0.70)
1.24 (0.89)
1.04 (0.13)

"p < 0.02 compared to samples with dialysed urine.
many as 74% were mixtures of calcium oxalate and calcium phosphate (unpublished results). Information on
the early steps of the formation of mixed calcium oxalate/calcium phosphate stones is insufficient due to
experimental difficulties, and there is no agreement on
whether calcium phosphate (Pak, 1969; Zarembski and
Grieve, 1976; Baumann, 1985; Lanzalaco et al., 1988;
Achilles et al., 1992) or calcium oxalate (Lonsdale,
1968; Finlayson, 1974; Sutor et al., 1974; Hodgkinson,
1977; Hartung and Leskovar, 1978) constitutes the
primary nucleus.

Discussion
It is reasonable to assume that renal stones composed of calcium salts start by a heterogeneous nucleation in a metastably supersaturated urine. Such a crystallization can theoretically be induced by free particles
in the solution or by the surfaces of cells lining the collecting system, with or without a contribution of macromolecules (Vermeulen and Lyon, 1968; Finlayson and
Reid, 1978; Finlayson, 1979; Rushton et al., 1981;
Hering et al., 1989). The most frequent constituent of
renal calcium stones is calcium oxalate and a recent
analysis of the composition of non-infection calcium
stones among our own patients revealed that whereas,
99 % of calcium stones contained calcium oxalate, as

Methodological

remarks

The composition of the solutions was chosen to
correspond to an average composition of the urine in the
respective parts of the nephron. This is undoubtedly an
over-simplification because the composition of urine is
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Figure 3. Scanning electron micrographs of the precipitate initially formed following addition of calcium to a PT sample without (A) and with (B) dialysed urine and a DTp sample without (C) and with (D) dialysed urine. Bars = 1 µm.
subject to a constant change during its passage through
the nephron. The most pronounced alteration probably
occurs during the concentration in the collecting duct
and although the composition in the proximal part of the
collecting duct is similar to that in the distal part of the
distal tubuli, the composition in the distal part of the
collecting duct will be similar to the final urine. To
cover the whole range of supersaturation in the neph ron,
we used a composition of the CD samples approximately
corresponding to that in the final urine.
Dialysed urine was added as a source of urinary
macromolecules.
We added dialysed urine in an amount
that very roughly corresponded to the dilution in the
nephron relative to the final urine. Both PT and DTp
samples were used with a 10% concentration of dialysed
urine, which for PT probably means a slightly higher
concentration of macromolecules than that encountered

physiologically, but no important differences were observed between samples with and without dialysed urine.
Although dialysed urine is an excellent source of
urinary macromolecules, it had two major drawbacks in
these experiments.
Firstly, we paid no attention to the
fact that some of the macromolecules are not normally
present at all levels of the nephron (Coe et al., 1991 a,b;
Hess, 1992), and secondly, macromolecules admixed
during the storage in the bladder might influence the
crystallization in a way that differs from the physiological situation (Martin et al., 1985; Edyvane, 1986).
This can, to some extent, be compensated for by adding
pure preparations of known crystallization
modifiers
such as nephrocalcin (Coe et al., 199 la, b), Tamm-Horsfall mucoprotein (Rose and Sulaiman, 1982; Yoshioka et
al., 1989; Coe et al., 199 la,b; Hess, 1992), and uropontin (Hoyer, 1992), but such an approach might also be
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Figure 4. Scanning electron micrographs of the precipitate initially formed following addition of calcium to DTd sample without (A) and with (B) dialysed urine and a CD sample without (C) and with (D) dialysed urine. Bars = 1 µm.
insufficient because all macromolecules that affect the
crystallization process are not yet identified (Atmani et
al., 1993). We made no attempt to assess quantitatively
the effect of urinary macromolecules, and for this reason, we used a urine-pool from normal subjects that was
available. Although acidification of the sediment might
damage a small fraction of urinary macromolecules, such
a mechanism is probably of less significance for the conclusions in this study.
The ion activity products in the various solutions
were calculated by means of repeated approximation
with the EQUIL2 program (Werness et al., 1985). No
corrections
were made for the complex-formation
between the several ions and urinary macromolecules
(Gill et al., 1977; Lian et al., 1977; Morse and Resnick,
1989; Nishio et al., 1990), and the ion-activity products
obtained for the samples with dialysed urine might,

therefore, in reality, be lower than the values presented.
This effect is probably less important for the low concentrations of dialysed urine present in the PT and DT
samples, but is certainly more important with the high
urine concentration used in the CD samples.
On the
other hand, it is likely that the macromolecules affect
the ion activities in a similar way before and after addition of calcium and oxalate.
The calculated estimates of APcaOx• APHAP and
APBru for the solution composition at the first appearance of crystals should not be taken for an estimate of
the formation product because in our Coulter counter
measurements, no particles were detected until they had
increased to a diameter of at least 3.5 µm. This should
be considered in view o(the fact that the critical cluster
size for calcium oxalate has been estimated to be 13 A
(Walton, 1967) and that of amorphous calcium phosphate
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9. 8 A (Nancollas, 1982). Crystals were microscopically
detected already at a calcium concentration in the CD
sample of approximately 5 mmol/1 which corresponds to
an APcaox of 2.13 x 10-8 . The recorded levels of
APHAP• APBru and APcaox at the first experimental evidence of crystal formation are, however, presumably
proportional to the actual formation products of the
salts.
Furthermore,
both calcium and oxalate were
added in a standardized way during a limited period of
time, during which a rapid precipitation was necessary
for detection of the crystallization.
It should also be
emphasized that the experiments were carried out in the
absence of particulate material (with a diameter above
0.22 µm) that normally might be present in the nephron
urine and also without the cellular lining that probably
is important for establishment of a fixed particle crystallization (Finlayson and Reid, 1978; Rushton et al.,
1981; Hering et al., 1989; Kohri et al., 1991; Mandel
and Riese, 1991).
It needs to be emphasized that the reproducibility
in non-seeded crystallization systems is inferior to that
in seeded systems (Nancollas, 1983). For this reason,
between 9 and 11 experiments were performed with each
solution.
Overall, the reproducibility was best in the
calcium experiments.
The coefficients of variation for
the increment of calcium at the first appearance of crystals in the pure salt solutions varied between 6.5 and
20.5%, and in solutions with dialysed urine between 9.2
and 28.5 % . The corresponding figures following addition of oxalate were between 2. 3 and 23. 0 % , and between 4.4 and 25 .1 % , respectively. Although considerable, this variation is acceptable in this type of experiments.
The variability in APHAP necessary for inducing
nucleation of calcium phosphate is remarkable but can
possibly be explained either by the different calcium/
phosphate or calcium/citrate ratios in the different solutions leading to different kinetics and different size
distributions during the early phase of the crystal formation process.

samples, and although the nucleation in reality starts at
lower concentrations than those determined with this
technique, it is reasonable to assume that the risk of calcium oxalate crystallization in these parts of the nephron
normally is extremely low.
In a recent study based on micropuncture studies
in animals, it was concluded that the loop of Henle was
at particular risk for precipitation of calcium phosphate
as well as of calcium carbonate (Coe and Parks, 1990;
Deganello et al., 1990). We have not carried out any
measurements with a composition corresponding to that
in the loop of Henle, but have assumed that the risk of
crystallization in this part of the nephron might be between that in PT and DTp, nor did we include CO 2 in
our calculations. Although this factor is fundamental for
determination of the risk of calcium carbonate nucleation, its effect on calcium phosphate is negligible.
It is
possible, however, that the counter current system in
this part of the nephron brings about changes in urine
composition that are difficult to predict.

Formation of crystals in DTd and CD samples
The increment in concentrations of calcium and
oxalate necessary for appearance of crystals in DTd and
CD samples were lower than those in PT and DTp samples. There were several observations supporting the
conclusion that the risk of calcium phosphate formation
in the DTd samples was higher than that of calcium oxalate. A higher relative increment of oxalate than of
calcium was required to start the crystallization.
In
addition, calcium phosphate was the predominant crystal
phase, at least early after the first appearance of crystals. Furthermore, there was no detectable reduction in
the concentration of 14C-oxalate remaining in solution,
when the concentration of calcium was increased beyond
the point of nucleation (Figure 2).
With the composition of the CD samples used in
these experiments, calcium oxalate was the predominant
crystal phase observed irrespective of whether oxalate or
calcium were added. The pH is certainly an important
determinant of crystal formation at increased concentrations of calcium under these conditions.
We used a pH
of 5.75, which might be an acceptable estimate of the
average pH of urine at this nephron level. The higher
pH following meals, and seen in association with acidification defects, will probably increase the risk of calcium
phosphate rather than calcium oxalate nucleation also in
this part of the nephron.
The increments in the concentrations of oxalate
necessary to get an AP caox at the level of the formation product (around 2 x 10-8 M2) would be approximately 0.20, 0.26, 0.55 and 0.32 mmol/1 for solutions
with compositions corresponding to urine in the proximal tubuli, the proximal part of the distal tubuli, the
distal part of the distal tubuli, and the collecting duct.
It is not likely that these concentrations will occur physiologically except in the collecting duct. Crystal nucleation on a surface with a suitable promoting lattice may,
however, be possible at lower levels of supersaturation.

Formation of crystals in PT and DTp-samples
The measurements in this investigation showed
that in solutions with a composition corresponding to
that in the proximal and distal tubuli, there was a greater
risk of forming crystals of calcium phosphate than of
calcium oxalate. This was in accordance with the supersaturation levels assumed to occur in urine at these levels of the nephron. Although an increased concentration
of oxalate resulted in nucleation of calcium oxalate, the
relative increment in oxalate required for crystal formation was higher than the relative increment of calcium.
Although crystals of calcium oxalate have been observed
at high levels of the nephron in animal experiments, this
was always seen in association with a considerable load
of oxalate (Kawada et al., 1976; Khan er al., 1979;
Rushton er al., 1981; Buck and Reis-Santos, 1990).
Very high relative increments were recorded for
oxalate in order to induce crystallization in PT and DTp
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The inhibiting influence of macromolecules on the
further development of crystals in the CD samples is
evident from the great difference in MCV-quotients
between pure salt solutions and salt solutions with
dialysed urine. A similar effect was not observed in
those samples in which calcium phosphate was the
primary product of crystallization.
Some factor in the dialysed urine might act as a
promoter of calcium oxalate precipitation. Such a mechanism has previously been suggested by other authors
(Phaneuf-Mimeault and Tawashi, 1977; Hallson and
Rose, 1979; Burns and Finlayson, 1980; Werness et al.,
1981; Drach et al., 1982; Rose and Sulaiman, 1984;
Khan et al., 1988; Morse and Resnick, 1989; Hackett et
al., 1990; Nishio et al., 1990) and is furthermore supported by the lower APcaox required for CaOx crystal
formation in the presence of dialysed urine following
addition of oxalate (Table 5).
There was a higher AP caox recorded at the first
appearance of crystals in the CD sample following addition of oxalate in comparison with that following addition of calcium, despite the fact that calcium oxalate
crystals were formed in both experiments. The calcium/
citrate ratio might thereby have influenced the early
development of crystals, that is, in the size range below
3.5 µm. It should be observed that the calcium/citrate
ratio in the CD sample without urine was 1.40 at the
first appearance of crystals following addition of oxalate
and 3. 74 following addition of calcium. A higher concentration of free citrate relative to the concentration of
calcium might have increased the aggregation inhibition
resulting in smaller particles and a later appearance of
crystals in the size range above 3.5 µm. However, calcium oxalate was the major crystal phase, both in the
calcium and the oxalate experiments.
Although calcium oxalate undoubtedly was the
predominant crystal phase in CD-samples, brushite crystals were later observed following further addition of
calcium . This is consistent with the supersaturation
levels of brushite encountered at the first appearance of
crystals in these samples. Brushite crystals apparently
occurred later than calcium oxalate crystals in as much
as their presence increased during storage of the sample.
Brushite crystals were found in DTd samples in which
APBru was above the solubility product, but below the
formation product. A proceeding crystallization during
preparation of the samples for microscopy might have
lowered the pH and further increased the supersaturation.
Irrespective of whether the primary nucleus is
amorphous calcium phosphate or brushite, it can be
stated that calcium phosphate is the crystal that most
easily will form in the distal tubuli.
Possible clinical significance of the observations
On the condition that our assumptions on the urine
composition in various parts of the nephron are reasonably correct, the results of the reported experiments lead
to some interesting speculations on the initial steps of
calcium oxalate stone formation. A high concentration

of calcium at the end of the distal tubuli, in the beginning of the collecting duct, or at both places, might result in the precipitation of calcium phosphate. This precipitate could then adhere to the surface of the nephron
cells. Following a slow migration to a lower level of the
collecting duct, these calcium phosphate crystals might
be able to induce nucleation of calcium oxalate in case
of a sufficiently high supersaturation level and a pH
below 6.5. The crystallization might occur either as a
heterogeneous growth of calcium oxalate directly on the
crystals of calcium phosphate or by a nucleation of calcium oxalate induced by the macromolecules adsorbed to
this material. The simultaneous nucleation of brushite
in the collecting duct urine might add further calcium
phosphate to the precipitate and also provide additional
promoting nuclei for calcium oxalate crystallization.
There is so far insufficient evidence for proof of such a
hypothesis, but the results obtained in this study clearly
show that the complexity of calcium oxalate stone formation most certainly cannot be disentangled by only regarding the crystallization properties in samples of
whole urine.
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Discussion with Reviewers
W.G. Robertson: Based on the authors' data, it would
seem unlikely that hypercalciuria per se can be considered as a major cause of crystal formation in most parts of
the nephron. What is the importance of hypercalciuria
in calcium stone disease?
Authors: The increase in calcium concentrations necessary for crystal formation in PT and DTp samples indicates that a crystallization of calcium phosphate induced
by hypercalciuria certainly is low at these levels. Also
in DTd and CD samples, it ·was necessary to increase
markedly the concentration of calcium in order to record
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Authors: The explanation for this phenomenon should
also be sought in the methodology.
Both calcium and
oxalate were added to the solutions in a standardized
way to facilitate a comparison between different samples. In addition to the fact that no crystals with a diameter below 3.5 µm were recorded with the Coulter counter technique, the samples were supersaturated to a higher level than that required for the formation of a critical
nucleus of approximately 10 to 13 A. The recorded ionactivity products are not estimates of the formation products but they will hopefully reflect a process that actually starts at much lower level of supersaturation.
It is
important to emphasize, however, that the concentration
of calcium and oxalate necessary for forming a 3. 5 µm
crystal is highly dependent upon the kinetics of crystal
growth and crystal aggregation during the early phase of
crystallization.
Based on the preliminary data reported
above, studies are now in progress aiming at a more accurate assessment of the risk of calcium oxalate and calcium phosphate in solutions with a composition corresponding to that in the distal part of the distal tubu!i and
in different parts of the collecting duct. Only following
such experiments will it be possible to draw any conclusions on the clinical significance of the risk of calcium
phosphate and calcium oxalate nucleation at these levels
of the nephron.

crystal formation, although the relative increment at
these concentration levels was much lower than in DTpsamples. No conclusions can be drawn, however, on the
calcium concentration required for nucleation, because
our method did not detect crystals until they had
achieved a diameter of at least 3.5 µm. Therefore, the
calcium concentration recorded for the first appearance
of crystals is much higher than that necessary for nucleation. The methods for assessing crystallization are not
sensitive enough to decide on the role of hypercalciuria.
The results, however, demonstrate that if an increased
excretion of calcium is of importance at these levels of
the nephron, then calcium phosphate is the most likely
product of crystallization in the distal tubuli. The risk
of calcium oxalate crystallization increases as the urine
moves further down the nephron in a direction towards
the distal part of the collecting duct.
W. G. Robertson: The activity products necessary to
produce crystallization of both calcium oxalate and calcium phosphate seem much higher than anticipated from
some other studies. What explanation do the authors
have for this observation?
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